protein adducts and induces mitochondrial oxidative stress.(1) Cytochrome P450 family 2 subfamily D member 6 (CYP2D6) contributed significantly to the formation of N-acetyl-p-benzoquinone imine (NAPQI), especially at toxic doses of acetaminophen when its plasma concentrations reached 2 mM or more.(2) Both at toxic concentration and therapeutic concentration, NAPQIglutathione was mostly formed by cytochrome P450 family 3 subfamily A member 4 (CYP3A4).(3) Very high doses of acetaminophen (e.g., 600 mg/Kg) can induce the mitochondrial permeability transition (MPT) independent of the cyclophilin D (CypD)-regulated MPT pore as a result of extreme oxidative stress.(4) Acetaminophen induce the apoptosis in liver cells and lymphocytes, which is caused by the ectopic expression of human caspase-3 and furthermore promotes the release of cytochrome C into the cytosol of treated cells. (5) The activation of caspase-3 might be characteristic of acetaminophen toxicity in fed mice and was not observed in starved animals due to the lower adenosine triphosphate (ATP) levels, which prevented caspase activation. (6, 7) Arcangelisia flava, that grows widely in Kalimantan Island, Indonesia, is a native plant of South East Asia. This plant has been empirically proven to cure hepatitis in Kalimantan and Sulawesi. Preliminary qualitative tests on wood mill of the stem part and root of this plant detected saponins, flavonoid, and alkaloids in high concentrations (8) , while further investigations of this plant had confirmed the presence of palmatine, berberine, jatrorrhizine, dihydroberberine and 20-hydroxyecdysone. (9) (10) (11) Berberine prevents inflammation, degeneration and death of liver cells in doxorubicin-induced mice. (12) This compound is effective in protecting the liver from acute CCl 4 -induced injury. The hepatoprotective mechanisms of berberine may be related to the free radical scavenging and attenuation of oxidative/nitrosative stress, as well as to the inhibition of inflammatory response in the liver. (13, 14) The pharmacological effects of A. gusanlung, a plant of the same genus, as well as its chemical constituents, had been explored. This plant showed weak cytotoxicity against the SGC 7901 human stomach cancer cell line with an inhibitory concentration (IC) 50 value of 85.1 µM (15), whereas A. flava leaves had been proven to exert cytotoxic activity on HeLa, MCF-7 breast cancer cell line, WiDr colon cancer cell line and Vero cell line with the IC 50 value of 467±70; 136±17; 213±79, and 1340±288 µg/mL respectively. The activity was selective on MCF-7 and WiDr, but unlikely on HeLa and Vero cell lines. (16) In this work, we investigated the hepato-protective effect Phytochemical Screening of A. flava Extract Phytochemical screening was carried out as per the standard methods described by Tiwari and colleagues at the Central Laboratory, Universitas Padjadjaran, Jatinangor, Indonesia. (18) of A. flava stem by measuring the expression of caspase-3 in acetaminophen-induced rat's liver, as well as the serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT) and gamma-glutamyl transferase (GGT) levels and the histology of the liver.
Methods

Materials
Experimental Design for Baseline Clinical Biochemistry Parameters
At day 0 th , the animals were fasted for 16 hours, and evaluated for their biochemical parameters (SGOT, SGPT, GGT) using 3 mL of orbital vein blood to obtain the baseline value. Serum was separated by centrifugation at 5,000 rpm for 10 minutes and utilized for the estimation of the biochemical parameters. The animals were then acclimatized for 7 days. At day 8 th , the animals were divided into seven groups, five in each group (19) as shown in Table 1 .
Liver/Body weight Ratio, Biochemical Analysis, and Qualitative Histological Study At day 21 st , the animals were re-evaluated for their clinical biochemistry parameters (SGOT, SGPT, GGT), then they were anaesthetized using overdosage of solid CO 2 and sacrificed. The liver was immediately dissected out, weighed, and transferred into Bouin solution for histological examination. The organs were then stained using hematoxyline and eosin, and the histological changes were observed under light-microscope and relevant findings were recorded on 40x magnification. This step was carried out at Laboratory of Animal Biosystem, Department of Biology, Faculty of Mathematics and Natural Science, Universitas Padjadjaran, Jatinangor, Indonesia.
western Blot Analysis
The fresh liver samples were selected randomly from each group and homogenized in radio immunoprecipitation assay buffer. Twenty-five µg of each liver protein were extracted using lysis buffer (0.5% SDS, 0.05 M Tris-HCl, adjust pH to 8.0) and sample buffer (1 M Tris-HCl pH 6.8, 50% gliserol, β-mercaptoethanol, 1% bromophenol blue and distilled water). The samples were heated at 95 o C for 5 minutes, loaded into 15% polyacrylamide gel, and run at 150 V for 2 hours. The resolved proteins were transferred Table 1 . Animal groups and the treatment for hepatotoxicity study.
to a polyvinylidene fluoride membrane using 200 mA for 30 minutes. The membranes were then incubated with goat anti-Caspase-3 antibody (1:1000) (Cat. #AAA65015) (R&D System, Minneapolis, USA) and mouse anti-GAPDH antibody (1:1000) (Cat. #AM4300) (Thermo Fisher Scientific Fremont, California, USA). After treatment with the primary antibodies, the membranes were washed and then incubated with secondary antibodies, horseradish peroxidase (HRP)-conjugated chicken anti-goat antibody (1:10000) (Cat. #sc-2953) (Santa Cruz Biotechnology Inc., California, USA) and HRP-conjugated chicken antimouse antibody (1:10000) (Cat. #sc-2954) (Santa Cruz Biotechnology Inc.). Each band was visualized by enhanced chemiluminescence (ECL) substrates (Cat. #926-95000) (Li-Cor Biosciences, Lincoln, USA) and the intensity of the band was normalized and measured using Image-J software. This step was performed at the Laboratory of Molecular Physiology, Division of Gene and Protein Analysis, Central Laboratory, Universitas Padjadjaran, Jatinangor, Indonesia.
Statistical Analysis
The obtained data were expressed as mean±SD and the differences between multiple groups were calculated by a one-way analysis of variances (ANOVA) with p-value of 0.05, followed by a nonparametric post hoc Duncan test. The statistical calculations were performed using SPSS for Windows version 16.0 (SPSS Inc., Chicago, USA). Table 2 shows the influence of A. flava stem extract on liver/body weight ratio of the acetaminophen-induced rats.
Results
Phytochemical Screening
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Ratio of Liver/Body weight and Biochemical Analysis
A. flava stem extract improved the liver/body weight ratio of the liver-injured animals.
Liver disease is the most important cause of increased SGPT activity and a common cause of increased SGOT activity. Several factors other than liver disease must be considered in interpreting SGOT and SGPT activities. In most types of liver disease, SGPT activity is higher than that of SGOT. The average SGOT in the blood serum before treatment was 93.66 U/L (normal range 63-175 U/L), whilst the average SGPT level was 55.89 U/L (normal range 19-48 U/L). (20) Data in Table 3 shows that acetaminophen administration resulted in the elevation of SGOT (3x compared to normal group), SGPT (3x compared to normal group) and GGT (5x compared to normal group) levels of the animals in group II which was treated only with PGA 2%. Pre-treatment with silymarin (group III) and higher doses of A. flava stem extract (group VI and VII) significantly prevented the biochemical changes induced by acetaminophen.
Our results were compared to the previous work on saponins of A. flava. Saponins were able to inhibit 58% of the increasing activity for SGOT and 52% for SGPT after 14 days of saponins administration. This is an indication that saponins of A. flava might have hepatoprotective activity. (8) Influence of A. flava stem extract on SGOT, SGPT and GGT of acetaminophen-induced rats is shown in Figure 1 .
Qualitative Histological Study
Our study clearly indicated that acetaminophen caused inflammation (Figure 2 ). Normal histology of the liver defines clear shape of the central vein (CV) and sinusoids, as showed in Figure 2A . In the acetaminophen-treated group, Figure 2B , severe lesion was observed occurs at the CV, the surrounding sinusoids were dilated, Kupffer cells migrated into the CV which indicates inflammation. These liver damages were also observed in group V Figure 2D and group VI Figure 2E , followed by a local haemorrhage (bold arrow) and statosis (thin arrow). Increasing doses of A. flava were proven could improve the condition of the liver in group VII Figure 2F similarly as was showed in positive control group Figure 2C and normal control Figure 2A .
western Blot Analysis
Western Blot analysis indicated an elevation of caspase-3 expression in negative control (Figure 3-6) . 
Discussion
Our study had demonstrated that acetaminophen caused a series of side effects including an increase of liver/body weight ratio, elevation of serum SGOT, SGPT and GGT levels, severe lesion at the CV, the dilation of the surrounding sinusoids, the migration of Kupffer cells into the CV, and furthermore a higher ratio of caspase-3/glyceraldehyde Ratio Protein Levels Caspase-3/β-actin furthermore an increasing of oxidative stress, associated with alterations in calcium homeostasis and initiation of signal transduction responses, causing mitochondrial permeability transition occurring with additional oxidative stress, loss of mitochondrial membrane potential, and loss of the ability of the mitochondria to synthesize ATP, and loss of ATP which leads to necrosis. (1, 3, 21) Overdose of acetaminophen also caused a temporary moderate caspase activation and generation of caspase-specific cleavage products of cytokeratin 18 in fed CD-1 mice. These effects could be prevented by caspase inhibitors although these inhibitors showed no impact on the overall liver injury.(6) Liver was proven not protected by caspase inhibitor treatment and no morphological evidence for apoptosis was detected. This result indicated that while modest caspase activation due to release of mitochondrial proteins occured, it is insufficient to actually cause significant apoptotic cell death. (22, 1) Previous study had reported that A. flava dose of 250 mg/Kg of BW prevented the elevation of SGOT and SGPT by carbon tetrachloride-induced hepatotoxicity in rat's liver.(23) Our study confirms that A. flava extract significantly prevent the elevation of SGOT, SGPT and GGT. Moreover, higher doses of A. flava extract indicate equal hepatoprotective activity with silymarin.
Caspase-3 is an inactive precursor in its full-length form (band 34 kDa in Figure 3 ), which herein is called procaspase. When the procaspase is cleaved (band 17 kDa), this particular protein will be activated and eventually induces degradation of DNA and condensation of cromatin cause apoptosis. (24) Peptide analog inhibitors of human caspase-3 had been investigated and revealed that caspase-3 and caspase-2 shared similar hydrophobic S5 sites, which furthermore showed difference in their selectivity for the P5 position of substrates. The distinct selectivity for P5 will assist in defining the particular substrates and signaling pathways associated with each caspase. (25) In this study, A. flava extract prevent the elevation of caspase-3 by inhibiting the cleaved of procaspase-3. This may be caused by the bonding between the extract with the active side of hydrophobic S5 site or P5 position of caspase-3. Furthermore, the ratio of caspase-3/GAPDH was calculated and proved that there was a significant reduction in the particular ratio of higher doses of the extract 200 and 400 mg/Kg of BW ( Figure 5-6 ). Therefore A. flava extract might be potential to be developed as a hepatoprotective agent. This activity is probably caused by secondary metabolites such as flavonoids, alkaloids, phenolics and saponins contained in the extract. Flavonoids and alkaloids in plants had been proven could play an important role in their hepatoprotective effect. (8, 12, 15, 26, 27) In
Conclusion
Higher dose A. flava extract shows hepatoprotective activity by preventing the elevation of serum transaminases and transferase levels. Eventually, no damage in the acetaminophen-induced rat's liver was observed. This plant modulates the expression of caspase 3 protein in dosedependent manner.
acetaminophen-induced hepatotoxicity, it might cause apoptosis and necrosis process in hepatocytes. Therefore, possible inhibition of protein expression in the early stages of apoptosis (such as caspase-9 and cytochrome-C) or necrosis (High mobility group box 1 (HMGB1) and microRNA-122) can be investigated.
